SCHEMBL1633265

SCHEMBL1633265

c1cc(Nc2ncc3ccc(OC4CCNCC4)cc3n2)cc(N2CCOCC2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 3/20 0.54
RIPK2 O43353 2/20 0.51
CDK2 P24941 3/20 0.51
CCNT1 O60563 2/20 0.51
CDK9 P50750 2/20 0.51
CCNE1 P24864 1/20 0.51
JAK2 O60674 2/20 0.51
TBK1 Q9UHD2 2/20 0.51
MAPK10 P53779 2/20 0.49
CCNA2 P20248 2/20 0.48
CDK5 Q00535 1/20 0.48
CDK5R1 Q15078 1/20 0.48
HDAC3 O15379 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
PLK4 O00444 1/20 0.45
PKMYT1 Q99640 1/20 0.44
NTRK1 P04629 1/20 0.44
GABRG2 P18507 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12724942 0.93 MARK3 (0.49) SYKRIPK2CDK2CCNT1CDK9
SCHEMBL1633417 0.91 MAPK10 (0.57) SYKCDK2CCNE1JAK2TBK1
SCHEMBL1633170 0.90 MAP4K1 (0.49) SYKCDK2CCNT1CDK9JAK2
SCHEMBL1633360 0.87 RIPK2 (0.49) SYKRIPK2CDK2CCNT1CDK9
SCHEMBL1634798 0.85 SYK (0.53) SYKCDK2CCNE1JAK2TBK1
SCHEMBL1634297 0.84 SYK (0.52) SYKCDK2CCNE1JAK2MAPK10
SCHEMBL12724944 0.84 MARK3 (0.46) RIPK2CDK2CCNT1CDK9CCNE1
SCHEMBL1633613 0.83 JAK2 (0.61) SYKRIPK2CDK2CCNT1CDK9
SCHEMBL12724910 0.81 SYK (0.49) SYKJAK2JAK1JAK3
SCHEMBL1633219 0.81 SYK (0.49) SYKJAK2NTRK1JAK1JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed